Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
59.50B | 53.97B | 45.67B | 38.90B | 35.96B | 35.14B | Gross Profit |
50.71B | 47.54B | 40.10B | 34.44B | 32.00B | 31.09B | EBIT |
6.92B | 8.27B | 7.28B | 6.32B | 5.47B | 4.93B | EBITDA |
10.23B | 13.27B | 10.18B | 8.80B | 7.66B | 6.96B | Net Income Common Stockholders |
6.70B | 7.23B | 6.41B | 5.41B | 4.80B | 4.76B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
16.30B | 18.24B | 16.96B | 14.64B | 10.54B | 11.09B | Total Assets |
72.02B | 72.47B | 65.10B | 56.59B | 49.44B | 51.00B | Total Debt |
7.39B | 6.43B | 8.33B | 10.37B | 13.52B | 18.00B | Net Debt |
-8.91B | -11.80B | -8.64B | -4.27B | 2.98B | 6.91B | Total Liabilities |
29.33B | 28.19B | 26.68B | 26.59B | 26.79B | 31.60B | Stockholders Equity |
42.69B | 44.28B | 38.42B | 29.99B | 22.66B | 19.40B |
Cash Flow | Free Cash Flow | ||||
3.09B | 6.06B | 5.59B | 7.81B | 4.73B | 3.99B | Operating Cash Flow |
3.19B | 9.77B | 8.50B | 9.82B | 6.77B | 5.59B | Investing Cash Flow |
-942.50M | -3.74B | -3.76B | -2.08B | -1.78B | -2.13B | Financing Cash Flow |
-3.31B | -5.02B | -3.04B | -3.99B | -5.22B | -3.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥123.55B | 19.89 | 2.02% | 12.93% | -14.89% | ||
72 Outperform | ¥43.78B | 54.42 | 1.54% | 18.96% | -13.13% | ||
54 Neutral | $5.38B | 3.40 | -45.06% | 3.28% | 16.75% | -0.02% | |
€598.11M | 43.81 | 12.05% | ― | ― | ― | ||
68 Neutral | ¥246.99B | 33.94 | 0.42% | 28.85% | 54.60% | ||
65 Neutral | ¥19.77B | 20.19 | 1.56% | 17.20% | 20.25% | ||
43 Neutral | ¥15.56B | 4,465.71 | 1.63% | -7.98% | -181.00% |